Study identifier:NIS-ORU-XXX-2014/2
ClinicalTrials.gov identifier:NCT02155998
EudraCT identifier:N/A
CTIS identifier:N/A
A Non-interventional Study of Postoperative or post-Radiation trEatment habits in locally adVanced prostate cancer patiENTs (high risk)- PREVENT
postoperative or postradiation adjuvant androgen deprivation therapy in locally advanced prostate cancer (high and very high risk) patients
N/A
No
-
Male
200
Observational
N/A
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Apr 2019 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|---|
PREVENT study patients Patients with locally advanced prostate cancer with high and very high risk of recurrence, who underwent surgery or radiotherapy within 3 months prior to enrolment, 18 years and older, consented to participate in this non-interventional study, being treated for prostate cancer in the oncology institutions / departments in the Russian Federation. | - |